UNSPSC 51262103: Tinazoline

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C11H11N3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 88174AK70T, chemically known as 1h-indole, 3-((4,5-dihydro-1h-imidazol-2-yl)thio)-, monohydrochloride but generally known as tinazoline, which bears US NIH Compound Identifier 68818. European Medicines Agency schedules Tinazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11073MIG. The term TINAZOLINE is an International Non-Proprietary Name.

UNSPSC 51262103 Tinazoline (Commodity) represents pharmaceutical products and medical supplies that state and local governments procure for public health, emergency response, and community health programs. Recent solicitations show that the code captures purchases of naloxone, drug deactivation systems, and related pharmaceutical interventions used by county health departments and emergency services to support substance-abuse response and harm-reduction initiatives. The work is typically solicited by county and municipal health departments through competitive bidding (IFB) processes with fixed-fee pricing, quarterly delivery schedules, and standard compliance requirements including drug-free workplace certification, E-Verify, insurance coverage, and federal regulatory adherence when federal funding is involved.

Seminole County, Florida posted IFB 60459723LAS in June 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the response deadline was July 26, 2023, with a two-year initial term and one-year renewal option. The code shows limited recent activity in the opportunities block; the single identified solicitation is geographically concentrated in Florida and does not establish a broader pattern of state-level or multi-jurisdiction activity under this Commodity code. Vendors pursuing opportunities under this code should anticipate fixed-fee pricing models, delivery logistics as a cost factor, and compliance with both state/local and federal requirements (including FEMA regulations when applicable) as standing contract conditions.